BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 27045512)

  • 21. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordant lymphoma consisting of mediastinal large B-cell lymphoma and nodular sclerosis Hodgkin lymphoma in the right supraclavicular lymph nodes: a case report.
    Zhang C; Yi Y; Chen C; Wang J; Liu Z
    Diagn Pathol; 2015 Dec; 10():215. PubMed ID: 26715530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling.
    Yuan J; Wright G; Rosenwald A; Steidl C; Gascoyne RD; Connors JM; Mottok A; Weisenburger DD; Greiner TC; Fu K; Smith L; Rimsza LM; Jaffe ES; Campo E; Martinez A; Delabie J; Braziel RM; Cook JR; Ott G; Vose JM; Staudt LM; Chan WC;
    Am J Surg Pathol; 2015 Oct; 39(10):1322-30. PubMed ID: 26135560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
    Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
    Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Godfrey J; Tumuluru S; Bao R; Leukam M; Venkataraman G; Phillip J; Fitzpatrick C; McElherne J; MacNabb BW; Orlowski R; Smith SM; Kline J
    Blood; 2019 May; 133(21):2279-2290. PubMed ID: 30910787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
    Gupta GK; Agrawal T; Pilichowska M
    BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
    Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
    Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of STAT6
    Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
    Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.
    Chao C; Xu L; Silverberg MJ; Martínez-Maza O; Chen LH; Castor B; Abrams DI; Zha HD; Haque R; Said J
    AIDS; 2015 Sep; 29(15):1943-51. PubMed ID: 26355571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
    Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
    Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas.
    Kim SJ; Hyeon J; Cho I; Ko YH; Kim WS
    Cancer Res Treat; 2019 Apr; 51(2):611-622. PubMed ID: 30025443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.
    Steidl C; Shah SP; Woolcock BW; Rui L; Kawahara M; Farinha P; Johnson NA; Zhao Y; Telenius A; Neriah SB; McPherson A; Meissner B; Okoye UC; Diepstra A; van den Berg A; Sun M; Leung G; Jones SJ; Connors JM; Huntsman DG; Savage KJ; Rimsza LM; Horsman DE; Staudt LM; Steidl U; Marra MA; Gascoyne RD
    Nature; 2011 Mar; 471(7338):377-81. PubMed ID: 21368758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.
    Takahata H; Ohara N; Ichimura K; Tanaka T; Sato Y; Morito T; Takata K; Kojima M; Kobata T; Yoshino T
    J Clin Exp Hematop; 2010; 50(2):121-7. PubMed ID: 21123970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.
    Chłopik A; Selim MA; Peng Y; Wu CL; Tell-Marti G; Paral KM; Shalin SC; Kraft S; Hsu CK; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
    Hum Pathol; 2018 Mar; 73():176-183. PubMed ID: 29307625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
    Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
    Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
    Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
    Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.
    Harris JA; Jain S; Ren Q; Zarineh A; Liu C; Ibrahim S
    Diagn Pathol; 2012 Jan; 7():12. PubMed ID: 22289504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-1 and PD-L1 Immunohistochemistry as a Diagnostic Tool for Classic Hodgkin Lymphoma in Small-volume Biopsies.
    Volaric A; Bacchi CE; Gru AA
    Am J Surg Pathol; 2020 Oct; 44(10):1353-1366. PubMed ID: 32649320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma.
    Mavili HS; Isisag A; Tan A; Miskioglu M; Baraz LS; Nese N
    Turk Patoloji Derg; 2021; 37(2):130-138. PubMed ID: 33085074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.